Theralase Technologies Inc. (TSXV:TLT)
Canada · Delayed Price · Currency is CAD 0.2600
-0.0150 (-5.45%)
Jul 3, 2026, 3:40 PM EST
Theralase Technologies Market Cap
Theralase Technologies has a market cap or net worth of CAD 76.87 million as of July 2, 2026. Its market cap has increased by 57.18% in one year.
Market Cap
76.87M
Enterprise Value
76.30M
Revenue
857.91K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.26
Market Cap Chart
Since April 2, 1996, Theralase Technologies's market cap has increased from 8.33M to 76.87M, an increase of 823.12%. That is a compound annual growth rate of 7.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 76.87M | 75.87% |
| Dec 31, 2025 | 43.71M | -33.43% |
| Dec 31, 2024 | 65.66M | 64.23% |
| Dec 28, 2023 | 39.98M | -42.29% |
| Dec 30, 2022 | 69.28M | -9.56% |
| Dec 31, 2021 | 76.60M | 97.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vector Science and Therapeutics | 375.49M |
| Profound Medical | 342.66M |
| Cannabix Technologies | 63.88M |
| Perimeter Medical Imaging AI | 40.66M |
| Cheelcare | 36.25M |
| Conavi Medical | 22.77M |
| Ventripoint Diagnostics | 21.01M |
| Aurora Spine | 19.91M |